Bingyi Chen

机构：Memorial Sloan Kettering Cancer Center, Sun Yat-sen University, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, First Affiliated Hospital of Xi'an Jiaotong University, University of Chinese Academy of Sciences, Guangzhou Medical University · ORCID：0000-0001-9525-2021

发表论文 82 篇 · 总被引 860 次 · h-index 20

代表论文

• SMARCA5 reprograms AKR1B1-mediated fructose metabolism to control leukemogenesis (2024 · Developmental Cell · 被引 23)
• Metal organic framework derived vanadium nitride anchored on nitrogen-doped carbon sheet as an efficient electrocatalyst for nitrogen reduction reaction (2024 · Surfaces and Interfaces · 被引 8)
• Apoptotic vesicles derived from bone marrow mesenchymal stem cells increase angiogenesis in a hind limb ischemia model via the NAMPT/SIRT1/FOXO1 axis (2025 · Stem Cell Research & Therapy · 被引 6)
• Enhancing CAR T Cell Efficacy By Modulating PI3K Signaling Via a Synthetic CD28 Rheostat (2024 · Blood · 被引 6)
• TP53 mutations and TET2 deficiency cooperate to drive leukemogenesis and establish an immunosuppressive environment (2025 · Journal of Clinical Investigation · 被引 5)
• Catalytic activity of Setd2 is essential for embryonic development in mice: establishment of a mouse model harboring patient-derived Setd2 mutation (2024 · Frontiers of Medicine · 被引 4)